Vitamin B12 is an essential vitamin from animal foods, sold as supplements and injections to prevent and correct deficiency, common with age, plant-based eating, stomach surgery, or long-term use of a diabetes drug or stomach-acid blockers. High-dose oral tablets reliably restore levels. With adequate levels, B12 alone has not improved memory or mood; longevity findings come from mice. Risk signals come mostly from vitamin combinations, population studies or case reports. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum vitamin B12 | Above 400 pg/mL (Life Extension) | Confirms repletion |
| Methylmalonic acid | 73–271 nmol/L (standard reference range) | Best functional marker of tissue B12 |
| Total homocysteine | 5.1–13.9 µmol/L (standard reference range) | Reflects combined B12 and folate status |
| Holotranscobalamin (active B12) | About 25–165 pmol/L, assay-dependent (standard reference range) | Early marker of active B12 |
| Hemoglobin | Women 12.0–15.5 g/dL; men 13.5–17.5 g/dL (standard reference range) | Confirms correction of anemia |
| Mean corpuscular volume (red-cell size) | Not specified in the ER | Paired with hemoglobin in the blood count |
| Serum potassium | 3.5–5.0 mmol/L (standard reference range) | Safety check when treating severe anemia |
| Kidney filtration rate (diabetic kidney disease only) | No established target; track change from own baseline | Safety check on high-dose combinations |
| Folate | Not specified in the ER | Paired with homocysteine; baseline in at-risk groups |
| Reticulocytes | Not specified in the ER | Early response when treating severe anemia |
| Iron | Not specified in the ER | Label-listed check before treatment |
Cadence: Baseline panel before starting; recheck methylmalonic acid, B12 and blood counts at 8–12 weeks after starting, then every 6–12 months while risk factors persist. When severe anemia is treated, potassium during the first 48 hours and reticulocytes from day 5 to 7.